Value of Expedited Drug Approvals for Cancer Care

jamanetwork.com November 29, 2016

This study examines potential benefits of cancer drugs approved by the FDA on the basis of surrogate endpoints.

cancer drugs FDA study

Fluid Personalization and Vasopressor Decisions in Early Sepsis Management

Fluid Personalization and Vasopressor Decisions in Early Sepsis Management

AKI Risk Factors in ICU Patients Using Colistin

AKI Risk Factors in ICU Patients Using Colistin

Clinical Outcomes in Critically Ill COVID-19 Unvaccinated Patients Admitted to the ICU

Clinical Outcomes in Critically Ill COVID-19 Unvaccinated Patients Admitted to the ICU

Haloperidol vs. Placebo in ICU Patients with Delirium

Haloperidol vs. Placebo in ICU Patients with Delirium

Trauma Room Two

Handbook of Sepsis

Alton’s Antibiotics and Infectious Disease: The Layman’s Guide to Available Antibacterials in Austere Settings

Pediatric Critical Care: A Primer for All Clinicians

Evidence-Based Critical Care

Psychological and Cognitive Impact of Critical Illness

Damage Control in Trauma Care: An Evolving Comprehensive Team Approach

Sepsis Management: PIRO and MODS

Extracorporeal Life Support for Adults

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Critical Care: A New Nurse Faces Death, Life, and Everything in Between